JP Morgan Chase
VCNX

JP Morgan Chase’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

JP Morgan Chase’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$7 – 7982
2023
Q4 		$7 Buy
+1
New +$12 ﹤0.01% 7440
2023
Q3 		– Hold
0
– – – 7395
2020
Q4 		– Hold
0
– – – 5998
2020
Q3 		– Hold
0
– – – 5852
2020
Q2 		– Hold
0
– – – 5766

Other funds holding VCNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase's VCNX Position: Q1 2024 in Review

JP Morgan Chase sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 1 share — an estimated $7 sold.

JP Morgan Chase first reported a position in VCNX in Q4 2023 and held it in 1 quarter. The position peaked at $7 in Q4 2023. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • JP Morgan Chase reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1 Vaccinex, Inc. Common Stock share in Q1 2024, an estimated $7.
  • JP Morgan Chase first reported a position in Vaccinex, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • JP Morgan Chase's Vaccinex, Inc. Common Stock position peaked at $7 in Q4 2023.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.